Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin +/- FMD with Chemo-IO in LKB1-inactive Lung Adenocarcinoma
NCT03709147Phase 2Unknown
- Start
- Oct 2018
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in lung adenocarcinoma. Status: unknown.
02
Drugs
metformin
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT03709147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709147.